1-alkyl-2-acetyl-sn-glycerol choline
28-day mortality
30-day death/all-cause readmission
30-day readmission rate
8-fluo-camp binding
abdominal problems
abnormal hr variability
abnormal liver texture
absorption function
accountable
accounting
acetylcholinesterase inhibitor pyridostigmine
acid
acquired heart failure
acs procedures
actin cytoskeleton pathways
active treatment
activities
activity
activity status index
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute heart failure trials
acute hf trials
acute pulmonary embolism
acute rv decompensation
acute treatment of heart failure
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adenoviral vector
adherence
adjunctive treatment
adjusted hazard ratio
administration
administration of contrast agent
administrative databases
administrative health data
admission median bnp levels
admission nt-probnp
admission to discharge
advanced disease
advanced heart failure
advanced heart failure therapy
adverse cardiovascular
adverse event rates
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic exercise training on peak oxygen consumption
aerobic metabolism
aerobic training
af pacientes
af type
af-free probability
affairs
afterload burden
age-dependent effect
aging
aim
air pollution
akt
albumin level
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
allopurinol rats
alphalisa immunoassays
ambient air pollution
ambulatory heart failure trial
ambulatory hf
ambulatory hf patients
ambulatory icd patients
ambulatory patients
american
ami mortality rates
amylotic pattern
an
anemia treatment
anesthetized dogs
ang ii infusion mouse model
angeli
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
ann arbor veterans
annular size reduction
ans
ans mice
anterior descending
anterior descending artery
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer
anti-inflammatory effects
antiarrhythmic medication
antirheumatic drug
antitumor activity
anxiety
aortic blood flow
aortic insufficient
aortic pressure curve
aortic valve insufficient
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical rotation
arg16
arg83gly
aric hf
aric hf model
arn
arrhythmia substrate
arrhythmia-related costs
art failure
arterial compliance
artificial pulse
atheromatous coronary disease
athletes
atp demand
atp production rates
atrial explant-derived c-kit
atrial fibrillation and congestive heart failure trial
atrial structure
autonomic nervous system activity
autopsy
avd variation
b
b-treated
b-type natriuretic peptide levels
band of activated caspase
baroreflex activity therapy
barriers to exercise
basal
basal contractility
basal rotations
baseline ecgs
baseline echocardiography
baseline electrocardiogram
baseline glomerular filtration rate
baseline hgb
baseline hrqol
baseline serum creatinine level
baseline sst2 status
bb dose
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt interval
beat-to-beat qt intervals
behavioural-change interventions
bem-crt
bet bromodomain-containing protein 4
bet inhibition
beta-blocker dose
beta-blocker hypo-response
beta-blocker therapy
bhlh transcription factor hand2
bioinformatic
biological
biomarker studies
biomarker-guided clinical trial design
biomarker-guided clinical trials
biomedical reasons
biomedical treatment
black ethnicity
black patients
black race
blacks
blockade
blood loss
blood pressure control
blood testing
blood work drawn
blood-flow paths
blunted cardiac β-ar responsiveness
blunts
bn
bnp level
bnp levels
bnp measurements
body composition
body fat distribution
body mass
body mass ratio
body weight
bone morphogenetic protein 4 expression
borderline
bottleneck
bottleneck stent model
bradycardia induced
bradycardic response
breakdown of atrial natriuretic peptide
breast cancer patients
breath-holding
breathing control
bridge to recovery
bridging therapy
bromodomain inhibition
bt
budget
burden of heart failure hospitalizations
c
c-kit
c-kt+ cell differentiation
c-kt+ cell yield
c-terminally processed forms
c-terminally truncated fragments
c57b
ca(2+)-uptake
cab
calf muscle
california office of statewide health planning and development patient discharge data
caloric restriction
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
cancer
cancers
canine model
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-k
cardiac centre
cardiac development
cardiac diameters
cardiac explant c-kit
cardiac explant-derived cells
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac irs1
cardiac l-type channel activity
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1
cardiac mena deletion
cardiac mrna levels
cardiac myocyte-specific mena overexpression
cardiac nurse
cardiac nurses
cardiac pathogenesis
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac rehabilitation care
cardiac risk
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac symptoms
cardiac t2
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiomyocyte-like cells
cardiomyopathic restriction to flow
cardioprotective effect
cardiopulmonary exercise variables
cardiovascular complications
cardiovascular conditions
cardiovascular event rate
cardiovascular event-free rate
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
cardorespiratory fitness
care
care management
care packages
carotid bodies
case report
case-control analysis
case-control study
caspase 3 expression
caspase-3 activity
caspase-3 gene expression
catabolic/anabolic imbalance
catabolism
catalytic
catecholamine infusions
catheter ablation of atrial fibrillation
catheter-based percutaneous revascularization
catheter-based revascularization
caucasian
cause mortality
cav1.3 channels
cd
cd hf
cd133
cd34+vegf2
cdp choline
cell expansion protocols
cells isolated
centers for medicare and medicaid
central glycosylated
central pattern generator
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf devices
cf lvad
cgm
cgm synthesis
cha2ds2vasc score
chagas
change
channels
charm programme
chart review
chelation choices
chelation regimes
chemical instability
chemotherapy-induced heart failure
chf atrial explants
chf inhibition of avp
chf patients
chf patients intubated
chf predictive model
chf treatments
chf visit rates
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
childhood malignant disease
chinese herbal medicine
chm
cholinephosphotransferase
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic advanced heart failure patients
chronic disease
chronic heart failure induced
chronic hf-ref
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology
chronic stable guideline-directed medical therapy
chronic β-ar stimulation
circulating cd34
circulating fragments
circulating mediator of insulin resistance
circulating nt-probnp
circulating plasma ne
circulatory arrest
circulatory derangement
claims
class i recommendations
class ii heart failure
clcnka snp
clin
clinic outpatients
clinical benefit
clinical care delivery
clinical change
clinical composite response
clinical deterioration
clinical diastolic dysfunction
clinical doppler echocardiography
clinical modification codes
clinical outcome
clinical practice
clinical prediction rule
clinical studies
clinical symptoms
clinical trial
clinical trial registries
clinical trials
clinical variables
clnka
clnka gg
clnka polymorphism
cm
cms metric
co correlated
cochrane effective practice
coefficient
cogeneration of nitrite
cognitive function
cognitive impairment
collagen density
colon
commissioning
competitive
computed tomographic angiography
computing readmissions
conditional gene-targeted hand2 mice
conduction abnormalities
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congenital lesions
congestion-like symptoms
congestive heart failure exacerbation
congestive heart failure phenotypes
congestive heart failure visits
congestive symptoms
conjunction
conservation
contact
contemporary heart failure
content-driven telehealth technology
contrast agent
control group
controlled trial investigating outcomes
cooper center
corporeal membrane oxygenation
cost
cost-effective
cost-effectiveness
cost-effectiveness limits
cost-effectiveness model
cost-effectiveness ratio
cost-minimization
costs
coupling
cox proportional hazard
cox proportional hazards
cp
cp-recommended pharmacological treatment
cpet guiding exercise rehabilitation
cps
creatine kinase activity
crf distribution
cronbach
crt group
crt implantation
crt off
crt on
crt on assignment
crt response
crt-d recipients
crude
crude rates of severe hyperkalemia
crude rr
cultured cardiomyocytes
cumulative
cumulative administration of doxorubicin
cumulative urine volume
currents
curve
cutoff
cutoff level
cutoff value
cv events
cystatin c level
cytotoxic effect
danish heart failure database
dapc protein levels
dash diet scores
data monitoring board
deactivation
debilitating stroke
deciles
decisions
decline
decongestion
decongestion end point
decoy
defects
defense mechanism
defibrillator-only therapy
delayed rhythm control
dementia
department of cardiology
depressed left ventricular
depression
depressive symptoms
derivation cohort
detergent
developmental chromatin remodeling
device
device implantation
device therapies
devices
diabetes status
diabetic zsf1 rats
diagnosis of heart failure
diagnostic performance
diagnostic procedure
diagnostic procedures
diagnostic test
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
diastolic properties
died
diet
diet adherence
diet group
diet in renal disease
diet score
diet scores
dietary interventions
dietary recommendations
dietary sodium restriction
differential g-protein coupling
diffuse myocardial changes
dilated poorly contracting ventricles
direct observation
direct renin inhibitors
disappearance
discharge patients
discharged alive
discharged patients
discrimination
discrimination improvement
disease groups
disease management
disease management programs
disease progression
disease recapitulates
distressing implantable cardioverter-defibrillator shocks
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic therapy
dm
dna accessibility
dogs
doppler early diastolic mitral annulus velocity
dose uptitration
dose-related gradient
double mutant
downstream
downward regression line shift
doxorubicin cardiotoxicity
doxorubicin efflux transporter abcc2
doxorubicin-induced heart failure
dp-4 inhibitors
driveline infection
driveline injury
drs deciles
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug discontinuation
drug dose
drug-free
drug-untreated failing hearts
dyn
dynamic
dynamic resistance training
e-septal correlated
e/e
e/e'lateral
e/e'mean
e/e'septal
e/emean
early rhythm control therapy
early risk of stroke
early transmitral blood flow velocity
early transmitral flow
early-onset
early-onset hf
ec coupling gain
ec/elateral
ec/eseptal
ecb
eccentric
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic evidence
echocardiographic measurements
echocardiographic measures
echocardiographic outcomes
echocardiographic predictors
echocardiographic score
echocardiographic systolic parameters
ecmo group
ecmo+vad group
ecmo+vad groups
economic
economic analysis
economic climate
economic evaluations
economic impact
economic models
economic savings
ed physicians
ed visits
egf
egf group
ejection
elastic n2bus segment
elderly
elderly patients hospitalized
electric remodeling
electrical activation
electrical activation sequence
electrical stimulation
electrocardiographic device
electrocardiographic measures
electromechanical behavior
electronic databases
elevated left atrial pressure
elevated resistin
eligibility
embryonic gene programs
emergency
emergency cardiac catheterization
emergency room practice
emotional status
emotional stress
emphasis-hf study
end point of death
end-diastolic dimension
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energy deficit
energy expenditure
enos-ser
enos-thr
enrollment
enrollment period
epigenetic changes
epigenetic readers
eplerenone in mild patients hospitalization
equipotent dosages
er kinase
erasers
erc induced recovery
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
et
et exerts
ethically
ethnic groups
european hf
evaluation
event rate
event-free rates
events
evidence
evidence based practice
evidence-based medications
evidence-based practices
evidence-based therapies
evidence-based treatments
exchange malfunctioning heartmate ii lvads
excised
exercise
exercise adherence
exercise duration
exercise group
exercise hemodynamic status
exercise modality
exercise performance
exercise programmes
exercise protocol
exercise time
exercise training
exercise training response
exercise training therapy
exercise-induced
exercise-induced pasp increase
exertion
exogenous variants induced
expenditure
expenditures
explant-derived progenitor
expression of pluripotency markers
extracorporeal
extracorporeal membrane oxygenation membrane
factorial trial
factors
failing fontan
failing heart
failing hearts
failure of cardiovascular reserve
families
fat
fat loss
fat mass index
fatigue
fee-for-service beneficiaries
fes group
fetal gene
ff
fiber
figure
filling formalism
financial burden
financial costs
financials
first-in-man evidence
first-time diagnosis of heart failure
fish lacking nucleolin
fit
fixed ring
fixed-rate atrial pacing
flow-mediated dilatation diameter
flutter
follow-up echocardiograms
follow-up exercise capacity
follow-up measurement
follow-up tests
follow-up visits
food-frequency
force
forkhead box
fpassive-sarcomere length relations
fractional flow reserve measurements
framingham heart study criteria
free-breathing pulse sequence
full-length scn5a
function
furosemide dose
futility
g-protein-coupled receptor kinase-2
gastrointestinal regions
gating movement
gdmt-treated nyha
gene expression profiling
general hospital
general linear models
genes coding
genomic reprogramming events
ghf
ghf-dx
ghg
ghm
ghpef
ght
gln27
global longitudinal strain
global proteomics
glu27
glu27 haplotype
glucose transporter
gly16
grading of recommendations assessment
gross national income per capita
grounded theory
gtpase rac1 activity
guideline
guideline-heart failure registry
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
h-dko mice
hab battery score
haemodynamic outcomes
haemodynamic stress
hand grip strength
handling
hb battery scores
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced
hdl-induced no production
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health behaviors
health care expenditures
health care providers
health care system
health insurance
health interventions
health outcomes
health per capita
health service planning
health service provision
health status
health system data
health systems
health-care budget
healthcare common procedure codes
healthcare programmes
healthy control
heart failure admission
heart failure admissions
heart failure care
heart failure cellular responses
heart failure clinic
heart failure discharges
heart failure disease
heart failure guidelines
heart failure home
heart failure hospitalization
heart failure mice model
heart failure mortality
heart failure nurses
heart failure patients
heart failure prone
heart failure rats
heart failure risk
heart failure t1-mapping
heart failure-related hospitalization
heart failure-related mortality
heart muscle cells
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heart-specific irs1
heartmate ii devices
heartmate ii exchange
heartmate ii implantation
heartmate ii insertion
heartmate ii lvad
heartware intl
heartware patients
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hemoglobin levels
hemolysis events
hepatic function
hf admissions
hf canine electromechanics
hf clinic
hf cpgs
hf epidemiology
hf evolution
hf hospital admissions
hf hospitalisations
hf hospitalization
hf induced
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf patient plasma
hf patients
hf prediction model
hf progression
hf rats
hf readmissions
hf registry
hf remodeling
hf resources
hf risk
hf risk factors
hf risk prediction
hf units
hf volume management
hf-action cohort
hf-induced remodeling aspects
hf-related cachexia
hf-related morbidity
hfe
hff
hfpef patients
hfpsi model
hfref therapy
hfvt
hg
hg β coefficient
hgb level
hhf
high mortality
high-cost medicare
high-dose bb
high-fat diet
high-frequency
high-volume eds
high-volume physicians
hnorm
hnorm group
hnorm groups
hospital admission
hospital days
hospital discharge
hospital length of stay
hospital mortality
hospital performance
hospital quality improvement
hospital rankings
hospital rates
hospital stay
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hr dynamics
hr variability/turbulence
hretn
hum-retn mice
human
human heart failure
human hf
human myocardial tissue
human rad q66p
human resistin
humanized male mice
humoral stimuli
hvad devices
hybrid system
hypertrophied heart
i-meta-iodobenzylguanidine
i-mib
i-mibg
i2
icd-hf
icu admission
icu mortality
idiopathic dilated cardiomyopathy cohort
if inhibitor ivabradine trial
imaging techniques
immunoreactive nt-probnp
impact of frailty
impaired cardiac energy metabolism
impaired lv relaxation
impaired systolic function
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implanted left-to-right interatrial shunt
implanted monitoring devices
in vivo inhibition
in-hospital adverse events
inactive cxl-1051
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incidence and mortality outcomes
incident cardiovascular events
incident hf
incident hf cases
income
incubation
index admission
index ami
index beat method
index ed visit
index hf
induce heart failure
induced
induced myocardial infarction
induced pluripotent stem cell-derived cardiomyocytes
inducible myocardial ischemia
inducing hyperkalemia
industrial areas
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin levels
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
influx
inhibition of protein kinase
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortality
inhospital outcomes
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient admissions
inpatient records
insertion
instability
insulin action
insulin receptor substrates
insulin-signaling
insulin-stimulated rates
insurance status
intact hearts
interleukin receptor family
intermediate frail
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal consistency
internal reliability
interventricular septum biopsies
intestinal morphology
intracellular antiadrenergic therapeutic strategy
intravenous atropine
intravenous inotropes
intravenous iron
intravenous metoprolol
intrinsic left ventricular dysfunction
intubation rates
invasive hemodynamic
ip
irael
iron
iron deficiency
iron-deficient adult patients
irrael
irs2 double-knockout
irs2 gene double-knockout
irs2 proteins
ischemic etiology
ischemic hf pathogenesis
ischemic-hypertensive cardiomyopathy
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isolated lvad
isolated myoctyes
isolated pump replacement
isoprenaline infusion
iv hf
ivabradine group
ivabradine unloads
japanese heart failure
joint associations
joint effect
kaiser permanente northern california
kaplan-meier
kccq scales
kd
kidney index score
knockdown
kv
kv4.3 channel mrnas
kv4.3 mrna levels
l-dko mice
l-type ca2
l-type channel inhibition
l-type channel isoforms
l-type channel-dependent processes
label-free shotgun proteomics
laboratory report
laboratory report model
laboratory variables
lack of hypertension
lancet
late-onset
late-onset hf
lateral wall
lb
lc-ms
lcx model
lead to hospitalisation
leaflet motion
leaflet repair
leaflet resection
lean zsf1
lean zsf1 group
left
left ventricular assist device implantation
left ventricular biopsies
left ventricular diastolic
left ventricular ejection
left ventricular filling pressure response
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular systolic
left ventricular tissue
left-hand grip strength
left-to-right interatrial shunting
leg strength
legal majority
length-force relationship
leu3-gly4
lf/hf ratio
liberal transfusion protocols
life-sustaining treatment
lipid-lowering therapy
literature
littermate controls
liver-specific irs1
load-corrected chronotropic response
log
logistic regression models
lokomat® system
long-term mortality
long-term ventricular assist device
longitudinal strain
low bp
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequency
low-sodium dash diet
low-volume ed cases
low-volume eds
low-volume physicians
lower limbs
lung weight
lv end systolic volume index
lv systolic dysfunction
lv systolic indices
lvad implantation
lvad insertion
lvad surgery
lying
mad-crt
madit-crt trial
magnetic
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system for treating advanced hf
magneticically levitated rotor
maintenance of sinus rhythm
maladaptive cardiac remodelling
maladaptive molecular processes
male sex
malignancies
malondialdehyde bound
mammalian
management strategies
markers
masked outcome assessments
mass spectrometric
md
mean ejection fraction
mechanical
mechanical cardiac
mechanical dyssynchrony
mechanical support devices
mechanism
mechanism of action
mechanism of cardiac dysfunction
mechanism of cardioprotection
mechanisms
mechanisms of disease
medical conditions
medical hospitalization
medical management
medical outcomes
medical records
medical resources
medical support
medical therapies
medical treatment guidelines
medical-sensitive outcome measures
medically managed diseases
medicare coverage
medicare fee-for-service
medicare inpatient data
medication regimen
mediterranean
mediterranean and dietary approaches to stop hypertension
mediterranean diet score
mena levels
mesenchymal transition markers
metabolic abnormalities
metabolic changes
metabolic enzymes
metabolic risk factors
metoprolol treatment
metric
mi-induced decreases
miania
mice
midwestern state
migration
mineralocortic receptor antagonists
mineralotic receptor
minnesota living with heart failure
mir-25 expression integrate
mistargeting
mitochondrial complex
mitochondrial damage induced
mitochondrial dysfunction induced
mitochondrial oxidative stress induced
mitochondrial proteome changes
mitochondrial ultrastructural
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral e/e
mitral filling flow volume
mitral stenosis reversed
mlhf
molecular biomarkers
molecular mechanism
morpholino-based knockdown of nucleolin
mortality predictors
mortality rate
mortality rates
mortality risk
mouse heart
mouse heart failure
mouse hearts
mouse hf model
mouse model
mouse myocardium
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mri-based models
mrna level
mrna levels
msms
mt
mt group
multicenter automatic defibrillator implantation
multiparametric echocardiographic score
multivariate cox regression
murine equivalent
murine myocardium
murine resistin
muscle strength
muscle strip stiffness
muscle strips
muscle-wasting syndrome
muscular strength
mutant
mutant mice
mv
mwt
myocardial delayed enhancement imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial t1 changes
myocardial titin hypophosphorylation
myocyte diameter
myofiber
myofiber shortening velocity
myofibre
myofibrillar ca(2+)-stimulated atpase activity
myosin binding protein-c phosphorylation
n
n-
n-terminal fragment
n-terminal pro-brain-type natriuretic peptide assessment
na+ channel mrna splice
na-terminal pro-b-type np
nad(p-oxidase subunit rac2
nafat
nanomolar doses
natriuretic peptide levels
natriuretic peptide system
natural vasodilatory
naturally occurring rad variant
ncd pinnacle
nct00180271)
negative coronary angiography
negative cross talk
neonatal rat ventricular cardiomyocytes
neprilysin blocks
neprilysin inhibitor prodrug
nesiritide strategy
net reclassification
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
nfat signalling
nicorandil ameliorates mitochondrial dysfunction
nights
ninth revision
nitric oxide donors
non-aas
non-biological disease
non-diabetic patients
non-diastolic abnormalities
non-dx
non-fatal stroke
non-frail
non-hf
non-ischemic
non-lbbb
non-linear hr variability measures
non-survivors
nonadherence
noncardiac
noncardiologist
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nonfunctional channels
nonglycosylated
nonpace
nonpace dnx
nonselective
nonsurvivors
nontrastuzumab
nontraumatic death
nordic walking
norepinephrine-induced hypertrophic responses
normal geometry
northwest united states
np assessment
np levels
np measurement
nt-probnp assay
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nurse assessment of cognitive impairment
nurse leaders
nursing care
nursing terminologies
nursing-sensitive outcome change scores
nutrition
nutritional abnormalities
nutritional strategies
nuts
nyha ii-iii
o-1 signaling
o2 consumption rate
obese body mass index
obese participants
obese zsf1
obese zsf1 groups
off-pump
office hours
oht bridged to transplant
onset af
open chest model
open stent
open surgery
open-label crossover
operating characteristic curve
operationalized hospital quality of care outcomes
operative outcomes
oral glucocorticoid dosage
oral glucocorticoids
organisation of care taxonomy
out-patient follow-up
outcome ratings
outcome-monitoring phase
outcomes trial
outpatient assessments
outpatient models
outpatient settings
overweight
overweight body mass index
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
p38alpha mapk
p38α mitogen-activated protein kinase
p70s6k-ser
pace dnx
pace non-dx
paced myocardium
paediatric cardiac transplants
paediatric heart failure
paf biosynthetic enzymes
paf levels
parasympathetic function
pasp relationship
passive/stiffness
pathological cardiac gene expression programme
pathological changes
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathological stress
pathophysiologic mechanism
pathophysiologic mechanisms
pathophysiological origin
pathway alterations
patient consultation
patient enrollment
patient management interventions
patient management interventions in heart failure
patient outcomes
patient safety
patient safety initiatives
pay-for-performance
pb cycle
pcp
pde superfamily
pde2 activity
pde2 expression
pde2 overexpression
pde2-overexpressing cardiomyocytes
peak o2 per kilogram
peak respiratory
pediatric heart failure
pediatrics
penalties
percutaneous coronary revascularization
percutaneous one-vessel model
peripheral abnormalities
perk activation destabilized scn5a
perk inhibition
permanent periodic breathing
permeability
perturbed mitochondrial function
pf cohort
pf-acetylhydrolase
pf-ah
pf-cpt
pg
pharmacologic studies
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
phenylephrine-induced genes
phosphomimic ser77
physical activity
physical exertion
physical exhaustion
physical volume
physician adherence
physician continuity
physician follow-up
physician volume
physiologic processes
physiological proteolysis
pigs
pilot trial
pkc-βii-ser
placebo-controlled clinical trial
plasma collected
plasma samples
plasticity
plateau phase
pluripotency marker nanog
poc measurement
point-of-care systems
policy recommendations
polytetrafluoroethylene tube
porcine model
positron emission tomography imaging
post myocardial infarction heart failure efficacy and survival study
post-aac
post-acute care transfer policy
post-dash
post-hct chf
post-myocardial infarction heart
post-myocardial infarction heart failure patients
post-myocardial infarction patients
post-tac cardiac
post-translational state
post-transplant morbidity
post-transplant mortality
posterior wall thickness
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative mortality
postoperative normalization
postoperative normalization of albumin levels
postoperative survival
pp
practice-level variation
pre-crt lv
pre-hct chest radiation
pre-hct exposure
pre-hct germline dna
pre-pd
precipitating factor
prediction rule
predictor
preferences
preoperative albumin
preoperative hypoalbuminemia
preoperative renal dysfunction
preoperative serum albumin levels
preserved
pressure
pressure development
pressure gradient
pressure-overload-induced hypertrophy
pressure-volume conductance catheter system
primary care clinicians
primary isolated cab
primary isolated cabg
primary oscillations
primary outcome of death
principal discharge
prior stroke score
pro2-leu3
pro6-gly7
proangiogenic effects
procedure
procedures
process redesign
processes of care delivery
production
prognostic benefit
prognostic factors
prognostic power
progression
progressive disease
prolapse of a degenerative mitral valve
propensity
propensity score decile
prostate
protective peptides
protein levels
protocol-driven poc testing
province of alberta
province of québec
proximal circumflex artery
pss
psychometric profile
psychometric testing
psychosocial factors
public health
public reporting
publicly
pulmonary arterial hypertension medication
pulmonary arterial systolic pressure relationship
pulmonary artery snared
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pump replacement
pump-exchange technique
pure epicatechin
pyridostigmine administration
q65p substitution
quality
quality of life assessment
quality of life score
quality-of-life score
quartile of e/e
quartiles
r-r interval oscillations
r. cluster analysis
rabbits
race
race by treatment
rad q65p
rad q66p
radial artery tonometry
radioenzymatic- and fluorescence resonance energy transfer-based assays
radiological signs
radituzumab administration
raised blood glucose levels
raloxifene-treated
randomized trials
ras axis
ras-
ras-blocker uptitration
rat
rat metabolic risk
rate
rate of death
rate of inappropriate atp
rate-control patients
rate-control strategies
rate-control treatment strategies
ratio
ratio ees
ratio of phosphocreatine
ratio of systolic blood pressure
ratios
rats
rcs
readmission metric
readmission metrics
readmission rate
readmission rates
readmission reduction program
readmission to hospital
receiver operating characteristic curve
reciprocal downregulation
reciprocal regulation
recommended therapies registry
recovery
recovery period
recreational athletes
reduction of cardiac na+ current
refill compliance
refractory
regulate expression
regulates ventricular action potential duration
regulation
regulation of feeding
regulation of programmed cell death
regulator
regulator of growth
regulatory
regulatory subunit
relative appendicular lean mass index
relative value
relaxation
religious beliefs
renal atherosclerotic lesions
reperfusion therapy
repolarization lability
report
reporting
reports
residual confounding
resistance training
resistin correlated
resistin levels
respiratory gas
response
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
retn gene
reversal of detrimental alterations
reverse cardiac remodeling
reverse remodeling parameters
reversibility
reversible causes
reversible myocardial ischemia
rhythm
rhythm- and rate-control
right atrial area
right atrial mass removal
right atrium mass
right grip strength
right ventricle overload leads
right ventricular contractil
right ventricular end-diastolic area
right ventricular fractional area change
right ventricular pump
risk
risk factor
risk model
risk of death
risk of event
risk reduction
risk-adjusted all-cause mortality
risk-adjusted mortality
riα proteins
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rose acute heart failure
rotterdam
routine measurement
rr intervals
rule
rv failure management
rv function evaluation
s'lateral
s'septal
s1pr
s1pr1 cardiac gene therapy
s1pr1 downregulation
s2
saf cohort
salt
salt intake
sandwich alphalisa
sarcomeric
scaffold protein drives
schfi
sci
science
scientific literature
scn5a mrna splicing
scn5a transcript
sdqt-to-sdr ratio
sdr
seattle heart failure model-predicted survival
secondary outcome of death
secondary study
self-care
self-care management scale
self-care of heart failure index
self-management counseling
self-management training
self-reported physical activity
septal defects
septal wall cs
sequence-specific binding
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 phosphorylation
ser96)
serial evaluation
serum factors
serum levels
serum potassium level
serum resistin levels
serum sodium levels
severe ai
severe cad
severe hyperkalemia
sex
sham
sham group
sham levels
sham-innervated
sham-inv
sham-nx
sham-operated
sham-operated animals
shams
sheet orientation
short-form quality of life
short-term mortality rates
shortened lvet
shortness of breath due to lung congestion
shotgun
shunt implantation
shunt implants
signal transduction cascade
signaling
signaling paradigms
signalling cascades
signalosome
signed-rank tests
single-payer
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass correlated
skeletal muscle sarcomere
skilled nursing facilities
skinfold thickness
skm growth
skm mitochondrial structure
slowed conduction
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
sn5a
snared
snp rs10927887
social mandate
social support
society
socioeconomic status
sodium-restricted dash diet
sodium-restricted dietary
solid ehrlich carcinoma
soluble guanylate cyclase
soluble st2
southeastern minnesota
sparing approach
sphingosine-1-phosphate receptor
spironolactone dose
spontaneous cardiac dysfunction
sport
sprague-dawley rats
sr ca(2+)-pump function
srd
srd brachial
sst2 concentrations
sst2 measurement
sst2 titrated
sst2/high-dose bb
sst2/low-dose bb
st2 level
st2 levels
stable coronary artery disease
stage i-iii breast cancer
standard cardiac rehabilitation
standard cardiac rehabilitation care
standard heart failure medicines
standard practice
standing blood pressure
statistical standards
statitistical
stem cell source
stenotic
stent coated
stent occlusion
stockholm national inpatient registry
stop hypertension diet
strain rate
strategy
stress conditions
stretch rate
stroke prevention trial
structural heart disease
structurally normal hearts
sts hh
sts hm
study
subcellular alterations
subclinical atherosclerosis
suburban hospitals
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
surface ecgs
surgical indication
surgical intervention
surgical method of transverse aortic constriction
surgical patients
surgical ring implantation
surgical tactics
survival
survival projections
survival study in heart failure
sustainability
svr index
swedish web-system for enhancement and development of evidence-based care
swine
swine model
sympathetic control
symptom domains
synchrony
syndrome of right heart failure
systemic/uv treatment
systolic heart failure treatment
systolic human heart failure
t test
t1-mapping mri
t1-mapping sequence
tac surgery
tac-
tac-induced heart failure
tac-induced proteomic alterations
tachy-
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
taxonomy
technical advisors
technology
telehealth system
temporal trends
temporary centrimag rvad
tension
tertiary referral centre
test-retest reliability
testosterone group
testosterone levels
testosterone status
tests
tests-retest reliability
texas cancer registry-medicare
tg
tg-β
tg-β inhibition
tg-β receptor
tg-β signaling
tgtetmena
tgtttmena
tgtttmena mice
thalassaemia
therapeutic functions
therapeutic interruption of activated neurohormonal systems
therapeutic potential
therapeutic strategies
therapeutic strategy
therapeutic targets
therapy refractory cardiogenic shock
thickness
thigh muscle
time domain
time to death
timing of myocardial infarction
tissue
tissue doppler imaging
tissuefaxs technology
titin isoforms
titin modification
tm interventions
tobacco
total cholesterol
toxicity
tpse
training-induced changes
trans
transcription
transcription factor dhand
transcription factor gata4
transcription factor networks
transforming growth factor
transgenic mice
transition
transitions of care
transitions of care program
transmitral e-wave
transmitral flow velocities
transplant ineligible patients
transplant pool
transplant-ineligible patients
transplantation eligibility status
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treatment
treatment algorithms
treatment for heart failure
treatment group effects
treatment of heart failure
treatment strategies
treatments
trial
trial investigating outcomes of exercise training
trials
trichrome blue histologic
trigger hemoglobin threshold
trp7) channel mrna
truncated
truncated na+ channels
tta
tunel assay
tunel method
twist
two-vessel disease model
u.s. food and drug administration
ultrastructural changes
um/va
um/va-rt cohorts
unanchors titin
unclear etiology
uncontrolled hypertension
undiagnosed heart disease
unfit
unfolded protein response regulates cardiac sodium current
unilateral
unintentional weight loss
university hospital
unloading of the heart
unplanned admission
unplanned readmission
untreated acf groups
upr effectors
upstream signal
urgent all-cause readmission
urgent cardiac transplant
urgent readmission
usual care
va cohort
va health care systems
va patients
va-rt
va-rt cohort
vad group
vad groups
vagal
vascular effects
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
veg
vegetables
vegfr2
vehicle
vehicle-treated rats
velocity of circumferential shortening
velocity time
ven
venous thrombolic events
ventricular ejection fraction
ventricular power index
ventricular structure
ventricular systolic hf tissue samples
ventricular wall stress
ventricularly paced
vet
viscoelastic
vivo phosphorylation sites
voltage-gated cardiac na+ channel
volume
waist circumference
walk distance
walk test
walk test distance
walking
wasting of fat
wave doppler echocardiography
wave ratio
waves
weak grip strength
weight
weight loss
western australian
western blot analysis
white
white rabbits
whole grain intake
wilcoxon
wild type
wild-type littermates
wistar rats
withdrawal of sympathetic tone
working hearts
workload
wrf
wt riα
x-ray absorptiometry
xo-mediated ros effects
yield
yielded hazard ratios
yorkshire swine
zebrafish
zf1 groups
zsf1 rats
zung
β-adrenergic receptor activation
β-adrenergic receptor stimulation
β-ar drive
β-blocker dose
β-blocker dose changes
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers therapy
β1ar overstimulation
β2-receptor haplotype status
